Startups

Boehringer Ingelheim logo

Boehringer Ingelheim

boehringer-ingelheim.comboehringer-ingelheim.cn

Boehringer Ingelheim is an independent, family-owned global biopharmaceutical group founded in1885 inIngelheim am Rhein, Germany, developing human and animal health medicines. Its research and partnerships include mental health and neuroscience, immunology, respiratory disease, oncology and digital therapeutics. Shashank Deshpande chairs the Board of Managing Directors and leads Human Pharma; the current six-member executive directory covers Group Functions, Innovation, IT and Global Business Services, Finance and Animal Health. Hubertus von Baumbach chairs the Shareholders’ Committee following theJuly2025succession; he is no longer recorded as the current executive-board chair. The corporate group makes strategic investments and commercial collaborations. Click Therapeutics’ April2026announcement explicitly identifies Boehringer Ingelheim as its Series D strategic investor, alongside separately dedicated commercialisation funding whose amount is undisclosed. That corporate-brand transaction is not automatically allocated to the separately incorporated Boehringer Ingelheim Venture Fund GmbH or its portfolio. The group’s ultimate parent and individual operating subsidiaries are distinct legal entities: historic consolidated reports identify C.H.BoehringerSohnAG&Co.KG, while the globalwebsite imprint identifies publisher BoehringerIngelheimInternationalGmbH, MainzHRB21063. Neither publisher nor ultimateparent is assumed to be the exact cash subscriber when a financing source names only the group brand. The profile is a qualified corporate-group investment identity, distinct from retained Venture Fund investor5635. Research budgets, grants, collaboration milestone ceilings, sustainability expenditure and venture-fund corporate allocations are not new company funding rounds or external LPfund closes.

Team

Armin WieslerArmin WieslerMember of the Board of Managing Directors — Animal Health
Frank HüblerFrank HüblerMember of the Board of Managing Directors — Finance
Harsha DeshmukhHarsha DeshmukhMember of the Board of Managing Directors — IT and Global Business Services
Hubertus von BaumbachChairman of the Shareholders’ Committee
Michael SchmelmerMichael SchmelmerVice Chairman of the Board of Managing Directors — Group Functions
Paola CasarosaPaola CasarosaMember of the Board of Managing Directors — Innovation
Shashank DeshpandeShashank DeshpandeChairman of the Board of Managing Directors and Human Pharma Lead

Investments